Maternal sucralose intake alters gut microbiota of offspring and exacerbates hepatic steatosis in adulthood

References

• Leung C, Rivera L, Furness JB, Angus PW. The role of the gut microbiota in NAFLD. Nat Rev Gastroenterol Hepatol. 2016;13(7):412. doi:10.1038/nrgastro.2016.85.
   Google Scholar
• Geva-Zatorsky N, Sefik E, Kua L, Pasman L, Tan TG, Ortiz-Lopez A, Yanortsang TB, Yang L, Jupp R, Mathis D, et al. Mining the human gut microbiota for immunomodulatory organisms. Cell. 2017;168(5):928–943.e11. doi:10.1016/j.cell.2017.01.022.
   Google Scholar
• Tamburini S, Nan S, Han CW, Clemente JC. The microbiome in early life: implications for health outcomes. Nat Med. 2016;22(7):713–722. doi:10.1038/nm.4142.
   Google Scholar
• Wankhade UD, Zhong Y, Kang P, Alfaro M, Chintapalli SV, Thakali KM, Shankar K. Enhanced offspring predisposition to steatohepatitis with maternal high-fat diet is associated with epigenetic and microbiome alterations. PLoS One. 2017;12(4):e0175675. doi:10.1371/journal.pone.0175675.
   Google Scholar
• Suez J, Korem T, Zeevi D, Zilberman-Schapira G, Thaiss CA, Maza O, Israeli D, Zmora N, Gilad S, Weinberger A, et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature. 2014;70(7521):181–186. doi:10.1038/nature13793.
   Google Scholar
• Swithers SE. Artificial sweeteners produce the counterintuitive effect of inducing metabolic derangements. Trends Endocrinol Metab Tem. 2013;24(9):431–441. doi:10.1016/j.tem.2013.05.005.
   Google Scholar
• Uebanso T, Ai O, Kitayama R, Yoshimoto A, Nakahashi M, Shimohata T, Mawatari K, Takahashi A. Effects of low-dose non-caloric sweetener consumption on gut microbiota in mice. Nutrients. 2017;9(6):560. doi:10.3390/nu9060560.
   Google Scholar
• Ruiz-Ojeda FJ, Plaza-Díaz J, Sáez-Lara MJ, Gil A. Effects of sweeteners on the gut microbiota: a review of experimental studies and clinical trials. Adv Nutr. 2019;10(suppl_1):S31–S48. doi:10.1093/advances/nmy037.
   Google Scholar
• Bian X, Chi L, Gao B, Tu P, Ru H, Lu K. Gut microbiome response to sucralose and its potential role in inducing liver inflammation in mice. Front Physiol. 2017;8:487. doi:10.3389/fphys.2017.00487.
   Google Scholar
• Dhurandhar D, Bharihoke V, Kalra S. A histological assessment of effects of sucralose on liver of albino rats. Morphologie. 2018;102(338):197–204. doi:10.1016/j.morpho.2018.07.003.
   Google Scholar
• Liu CW, Chi L, Tu P, Xue J, Ru H, Lu K. Quantitative proteomics reveals systematic dysregulations of liver protein metabolism in sucralose-treated mice. J Proteomics. 2019;196:1–10. doi:10.1016/j.jprot.2019.01.011.
   Google Scholar
• Olivier-Van Stichelen S, Rother KI, Hanover JA. Maternal exposure to non-nutritive sweeteners impacts progeny’s metabolism and microbiome. Front Microbiol. 2019;10:1360. doi:10.3389/fmicb.2019.01360.
   Google Scholar
• Sangild PT. Gut responses to enteral nutrition in preterm infants and animals. Exp Biol Med. 2006;231(11):1695–1711. doi:10.1177/153537020623101106.
   Google Scholar
• Innis SM, Dai C, Wu X, Buchan AM, Jacobson K. Perinatal lipid nutrition alters early intestinal development and programs the response to experimental colitis in young adult rats. Am J Physiol Gastrointest Liver Physiol. 2010;299(6):G1376. doi:10.1152/ajpgi.00258.2010.
   Google Scholar
• Dai X, Wang B. Role of gut barrier function in the pathogenesis of nonalcoholic fatty liver disease. Gastroenterol Res Pract. 2015;2015:1–6. doi:10.1155/2015/287348.
   Google Scholar
• Anderson JM, Van Itallie CM. Tight junctions and the molecular basis for regulation of paracellular permeability. Am J Physiol. 1995;269:467–475.
   Google Scholar
• Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, Almeida M, Arumugam M, Batto JM, Kennedy S, et al. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013;500:541–546.
   Google Scholar
• Wu TR, Lin CS, Chang CJ, Lin TL, Martel J, Ko YF, Ojcius DM, Lu CC, Young JD, Lai HC. et al. Gut commensal Parabacteroides goldsteinii plays a predominant role in the anti-obesity effects of polysaccharides isolated from Hirsutella sinensis. Gut. 2018;68:248–262. gutjnl-2017-315458.
   Google Scholar
• Yamei Y, Yujia P, Jilong T, Mi J, Lu L, Li X, Ran L, Zeng X, Cao Y. Effects of anthocyanins from the fruit of Lycium ruthenicum Murray on intestinal microbiota. J Funct Foods. 2018;48:533–541. doi:10.1016/j.jff.2018.07.053.
   Google Scholar
• Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444(7122):1027–1031. doi:10.1038/nature05414.
   Google Scholar
• Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology. 2014;146(6):1489–1499. doi:10.1053/j.gastro.2014.02.009.
   Google Scholar
• Zhang C, Zhang M, Pang X, Zhao Y, Wang L, Zhao L. Structural resilience of the gut microbiota in adult mice under high-fat dietary perturbations. Isme J. 2012;6(10):1848–1857. doi:10.1038/ismej.2012.27.
   Google Scholar
• Willing BP, Dicksved J, Halfvarson J, Andersson AF, Lucio M, Zheng Z, Järnerot G, Tysk C, Jansson JK, Engstrand L, et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology. 2011;139(6):1844–1854.e1. doi:10.1053/j.gastro.2010.08.049.
   Google Scholar
• Kang C, Wang B, Kaliannan K, Wang X, Lang H, Hui S, Huang L, Zhang Y, Zhou M, Chen M, et al. Gut microbiota mediates the protective effects of dietary capsaicin against chronic low-grade inflammation and associated obesity induced by high-fat diet. MBio. 2017;8(3):e00470–17. doi:10.1128/mBio.00470-17.
   Google Scholar
• Porras D, Nistal E, Martínez-Flórez S, Pisonero-Vaquero S, Olcoz JL, Jover R, González-Gallego J, García-Mediavilla MV, Sánchez-Campos S. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation. Free Radic Biol Med. 2016;102:188–202. doi:10.1016/j.freeradbiomed.2016.11.037.
   Google Scholar
• Clausen MR, Mortensen PB. Kinetic studies on colonocyte metabolism of short chain fatty acids and glucose in ulcerative colitis. Gut. 1995;37(5):684. doi:10.1136/gut.37.5.684.
   Google Scholar
• Chu H, Duan Y, Yang L, Schnabl B. Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease. Gut. 2019;68(2):359–370. doi:10.1136/gutjnl-2018-316307.
   Google Scholar
• Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014;157(1):121–141. doi:10.1016/j.cell.2014.03.011.
   Google Scholar
• Nash MJ, Frank DN, Friedman JE. Early microbes modify immune system development and metabolic homeostasis—the “Restaurant” hypothesis revisited. Front Endocrinol (Lausanne). 2017;8:349. doi:10.3389/fendo.2017.00349.
   Google Scholar
• Kim B, Park K, Ji Y, Park S, Holzapfel W, Hyun C. Protective effects of Lactobacillus rhamnosus GG against dyslipidemia in high-fat diet-induced obese mice. Biochem Biophys Res Commun. 2016;473(2):530–536. doi:10.1016/j.bbrc.2016.03.107.
   Google Scholar
• Wesolowski SR, Kasmi KCE, Jonscher KR, Friedman JE. Developmental origins of NAFLD: a womb with a clue. Nat Rev Gastroenterol Hepatol. 2016;14(2):81. doi:10.1038/nrgastro.2016.160.
   Google Scholar
• Soderborg TK, Clark SE, Mulligan CE, Janssen RC, Babcock L, Ir D, Young B, Krebs N, Lemas DJ, Johnson LK, et al. The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD. Nat Commun. 2018;9(1):4462. doi:10.1038/s41467-018-06929-0.
   Google Scholar
• Moser VC, Mcdaniel KL, Woolard EA, Phillips PM, Franklin JN, Gordon CJ. Impacts of maternal diet and exercise on offspring behavior and body weights. Neurotoxicol Teratol. 2017;63:S0892036217300478. doi:10.1016/j.ntt.2017.07.002.
   Google Scholar
• Chia AR, Chen LW, Lai JS, Wong CH, Neelakantan N, Van dam RM, Chong MFF. Maternal dietary patterns and birth outcomes: a systematic review and meta-analysis. Adv Nutr. 2019;10(4):685–695. doi:10.1093/advances/nmy123.
   Google Scholar
• Abou-Donia M, El-Masry E, Abdel-Rahman A, Mclendon R, Schiffman S. Splenda alters gut microflora and increases intestinal P-Glycoprotein and cytochrome P-450 in male rats. J Toxicol Environ Health. 2007;71(21):1415–1429. doi:10.1080/15287390802328630.
   Google Scholar
• King V, Dakin RS, Liu L, Hadoke PWF, Walker BR, Seckl JR, Norman JE, Drake AJ. Maternal obesity has little effect on the immediate offspring but impacts on the next generation. Endocrinology. 2013;154(7):2514–2524. doi:10.1210/en.2013-1013.
   Google Scholar
• Mulligan CM, Friedman JE. Maternal modifiers of the infant gut microbiota: metabolic consequences. J Endocrinol. 2017;235(1):JOE-17-0303. doi:10.1530/JOE-17-0303.
   Google Scholar
• Noah TK, Donahue B, Shroyer NF. Intestinal development and differentiation. Exp Cell Res. 2011;317(19):2702–2710. doi:10.1016/j.yexcr.2011.09.006.
   Google Scholar
• Lillycrop KA, Burdge GC. Epigenetic mechanisms linking early nutrition to long term health. Best Pract Res Clin Endocrinol Metab. 2012;26(5):667–676. doi:10.1016/j.beem.2012.03.009.
   Google Scholar
• Liu P, Che L, Yang Z, Feng B, Che L, Xu S, Lin Y, Fang Z, Li J, Wu D, et al. A maternal high-energy diet promotes intestinal development and intrauterine growth of offspring. Nutrients. 2016;8(5):258. doi:10.3390/nu8050258.
   Google Scholar
• Fang Y, Liu L, Cao H, Moore DJ, Washington MK, Wang B, Peek RM, Acra SA, Polk DB. Neonatal colonization of mice with LGG promotes intestinal development and decreases susceptibility to colitis in adulthood. Mucosal Immunol. 2016;10(1):117–127. doi:10.1038/mi.2016.43.
   Google Scholar
• Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, Pettersson S. Host-gut microbiota metabolic interactions. Science. 2012;336(6086):1262–1267. doi:10.1126/science.1223813.
   Google Scholar
• Ferretti P, Pasolli E, Tett A, Asnicar F, Gorfer V, Fedi S, Armanini F, Truong DT, Manara S, Zolfo M, et al. Mother-to-infant microbial transmission from different body sites shapes the developing infant gut microbiome. Cell Host Microbe. 2018;24(1):133–145.e5. doi:10.1016/j.chom.2018.06.005.
   Google Scholar
• Omran A, Ahearn G, Bowers D, Swenson J, Coughlin C. Metabolic effects of sucralose on environmental bacteria. J Toxicol. 2013 Dec 3 2013;2013(4):372986. doi:10.1155/2013/372986.
   Google Scholar
• Carmen CM, Samuli R, Juhani A, Erika I, Seppo S. Human gut colonisation may be initiated in Utero by distinct microbial communities in the placenta and amniotic fluid. Sci Rep. 2016;6(23129):23129. doi:10.1038/srep23129.
   Google Scholar
• Cox LM, Yamanishi S, Sohn J, Alekseyenko A, Leung J, Cho I, Kim S, Li H, Gao Z, Mahana D, et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell. 2014;158(4):705–721. doi:10.1016/j.cell.2014.05.052.
   Google Scholar
• Hill DA, Artis D. Intestinal bacteria and the regulation of immune cell homeostasis. Annu Rev Immunol. 2010;28(28):623–667. doi:10.1146/annurev-immunol-030409-101330.
   Google Scholar
• Gensollen T, Iyer SS, Kasper DL, Blumberg RS. How colonization by microbiota in early life shapes the immune system. Science. 2016;352(6285):539–544. doi:10.1126/science.aad9378.
   Google Scholar
• Geuking MB, Cahenzli J, Lawson MA, Ng DK, Slack E, Hapfelmeier S, McCoy K, Macpherson A. Intestinal bacterial colonization induces mutualistic regulatory T cell responses. Immunity. 2011;34(6):794–806. doi:10.1016/j.immuni.2011.03.021.
   Google Scholar
• Tanoue T, Atarashi K, Honda K. Development and maintenance of intestinal regulatory T cells. Nat Rev Immunol. 2016;16(5):5. doi:10.1038/nri.2016.36.
   Google Scholar
• Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, Cheng G, Yamasaki S, Saito T, Ohba Y, et al. Induction of colonic regulatory T cells by indigenous clostridium species. Science. 2011;331(6015):337–341. doi:10.1126/science.1198469.
   Google Scholar
• Gonçalves P, Araújo JR, Di SJ. A cross-talk between microbiota-derived short-chain fatty acids and the host mucosal immune system regulates intestinal homeostasis and inflammatory bowel disease. Inflamm Bowel Dis. 2018;24:558.
   Google Scholar
• Nakajima A, Kaga N, Nakanishi Y, Ohno H, Miyamoto J, Kimura I, Hori S, Sasaki T, Hiramatsu K, Okumura K, et al. Maternal high fiber diet during pregnancy and lactation influences regulatory T cell differentiation in offspring in mice. J Immunol. 2017;199(10):3516–3524. doi:10.4049/jimmunol.1700248.
   Google Scholar
• Gao X, Cao Q, Cheng Y, Zhao D, Wang Z, Yang H, Wu Q, You L, Wang Y, Lin Y, et al. Chronic stress promotes colitis by disturbing the gut microbiota and triggering immune system response. Proc Natl Acad Sci. 2018;115(13):201720696. doi:10.1073/pnas.1720696115.
   Google Scholar
• Park J, Kim M, Kang SG, Jannasch AH, Cooper B, Patterson J, Kim CH. Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway. Mucosal Immunol. 2015;8(1):80–93. doi:10.1038/mi.2014.44.
   Google Scholar
• Chang PV, Hao L, Offermanns S, Medzhitov R. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci U S A. 2014;111(6):2247–2252. doi:10.1073/pnas.1322269111.
   Google Scholar
• Gomez de Agüero M, Ganal-Vonarburg SC, Fuhrer T, Rupp S, Uchimura Y, Li H, Steinert A, Heikenwalder M, Hapfelmeier S, Sauer U, et al. The maternal microbiota drives early postnatal innate immune development. Science. 2016;351(6279):1296–1302. doi:10.1126/science.aad2571.
   Google Scholar
• Nash MJ, Frank DN, Friedman JE. Early microbes modify immune system development and metabolic homeostasis-the “Restaurant” hypothesis revisited. Front Endocrinol (Lausanne). 2017;8:349. doi:10.3389/fendo.2017.00349.
   Google Scholar
• Tilg H, Zmora N, Adolph TE, Elinav E. The intestinal microbiota fuelling metabolic inflammation. Nat Rev Immunol. 2020;20(1):40–54. doi:10.1038/s41577-019-0198-4.
   Google Scholar
• Peng L, Li ZR, Green RS, Holzman IR, Lin J. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr. 2009;139(9):1619–1625. doi:10.3945/jn.109.104638.
   Google Scholar
• Zhou D, Pan Q, Xin FZ, Zhang R-N, He C-X, Chen G-Y, Liu C, Chen Y-W, Fan J-G. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier. World J Gastroenterol. 2017;23(1):60–75. doi:10.3748/wjg.v23.i1.60.
   Google Scholar
• Endo H, Niioka M, Kobayashi N, Tanaka M, Watanabe T. Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: new insight into the probiotics for the gut-liver axis. PLoS One. 2013;8(5):e63388. doi:10.1371/journal.pone.0063388.
   Google Scholar
• Wieland A, Frank DN, Harnke B, Bambha K. Systematic review: microbial dysbiosis and nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 2015;42(9):1051–1063. doi:10.1111/apt.13376.
   Google Scholar
• Schnabl B, Brenner DA. Interactions between the intestinal microbiome and liver diseases. Gastroenterology. 2014;146(6):1513–1524. doi:10.1053/j.gastro.2014.01.020.
   Google Scholar
• Sellmann C, Priebs J, Landmann M, Degen C, Engstler AJ, Jin CJ, Gärttner S, Spruss A, Huber O, Bergheim I, et al. Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time. J Nutr Biochem. 2015;26(11):1183–1192. doi:10.1016/j.jnutbio.2015.05.011.
   Google Scholar
• Li Y, Liu T, Yan C, Xie R, Guo Z, Wang S, Zhang Y, Li Z, Wang B, Cao H. Diammonium glycyrrhizinate protects against non-alcoholic fatty liver disease in mice through modulation of gut microbiota and restoring intestinal barrier. Mol Pharm. 2018;15:3860–3870. acs.molpharmaceut.8b00347.
   Google Scholar
• Xie R, Sun Y, Wu J, Huang S, Jin G, Guo Z, Zhang Y, Liu T, Liu X, Cao X, et al. Maternal high fat diet alters gut microbiota of offspring and exacerbates DSS-induced colitis in adulthood. Front Immunol. 2018;9:2608.
   Google Scholar
• Rau M, Rehman A, Dittrich M, Groen AK, Hermanns HM, Seyfried F, Beyersdorf N, Dandekar T, Rosenstiel P, Geier A, et al. Fecal SCFAs and SCFA-producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T-cell activation and advanced disease. United Eur Gastroenterol J. 2018;6(10):1496–1507. doi:10.1177/2050640618804444.
   Google Scholar
• Wang L, Zhang J, Guo Z, Kwok L, Ma C, Zhang W, Lv Q, Huang W, Zhang H. Effect of oral consumption of probiotic lactobacillus planatarum P-8 on fecal microbiota, SIgA, SCFAs, and TBAs of adults of different ages. Nutrition. 2014;30(7–8):776–783.e1. doi:10.1016/j.nut.2013.11.018.
   Google Scholar
• Cassir N, Benamar S, La Scola B. Clostridium butyricum: from beneficial to a new emerging pathogen. Clin Microbiol Infect. 2016;22(1):37–45. doi:10.1016/j.cmi.2015.10.014.
   Google Scholar
• Seki H, Shiohara M, Matsumura T, Miyagawa N, Tanaka M, Komiyama A, Kurata S. Prevention of antibiotic-associated diarrhea in children by Clostridium butyricum MIYAIRI. Pediatr Int. 2003;45(1):86–90. doi:10.1046/j.1442-200X.2003.01671.x.
   Google Scholar
• Mo S, Kim BS, Yun SJ, Lee JJ, Yoon SH, Oh CH. Genome sequencing of clostridium butyricum DKU-01, isolated from infant feces. Gut Pathog. 2015;7(1):8. doi:10.1186/s13099-015-0055-3.
   Google Scholar
• Yasueda A, Mizushima T, Nezu R, Sumi R, Tanaka M, Nishimura J, Kai Y, Hirota M, Osawa H, Nakajima K, et al. The effect of Clostridium butyricum MIYAIRI on the prevention of pouchitis and alteration of the microbiota profile in patients with ulcerative colitis. Surg Today. 2016;46(8):939–949. doi:10.1007/s00595-015-1261-9.
   Google Scholar
• Chen D, Jin D, Huang S, Wu J, Xu M, Liu T, Dong W, Liu X, Wang S, Zhong W, et al. Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota. Cancer Lett. 2020;469:456–467. doi:10.1016/j.canlet.2019.11.019.
   Google Scholar